Concepedia

Author

Martin Bentz

German Cancer Research Center

Also Known As

Bentz, M, Bentz, M., Bentz, Martin, D W Beelen, M Bentz, M. Bentz, M. Schatz, M.- H. Bentz, M.-H. Bentz, M.H. Bentz

239

Publications

15.4K

Citations

61

H-Index

121

Concepts

All Affiliations

German Cancer Research CenterHeidelberg UniversityDKFZ-ZMBH AllianceUniversität UlmStädtisches Klinikum Karlsruhe
MB

About

Martin Bentz is an author at German Cancer Research Center specializing in medicine, pathology, and genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

48

4.4K

2

Health Sciences

18

20

2.1K

3

Engineering

2

2

149

4

Language Studies

2

2

56

5

Natural Sciences

1

1

297

Martin Bentz

×

107

Publications

13.7K

Citations

58

H-Index

YearCitations

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

Hartmut Döhner, Stephan Stilgenbauer, Axel Benner,

New England Journal of Medicine

2000

3.3K

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner, Konstanze Fischer, Martin Bentz,

Blood

1995

732

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

Andreas Engert, Volker Diehl, Jeremy Franklin,

Journal of Clinical Oncology

2009

494

11q Deletions Identify a New Subset of B-Cell Chronic Lymphocytic Leukemia Characterized by Extensive Nodal Involvement and Inferior Prognosis

Hartmut Döhner, Stephan Stilgenbauer, Michael R. James,

Blood

1997

437

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe,

The Lancet

2017

372

Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene

Stefan Joos, MI Otano-Joos, Sebastian Ziegler,

Blood

1996

331

Quantitative analysis of comparative genomic hybridization

Stanislas du Manoir, Evelin Schröck, Martin Bentz,

Cytometry

1995

297

Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.

Stefan Joos, M Küpper, S. Öhl,

PubMed

2000

278

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Norbert Schmitz, Maike Nickelsen, Marita Ziepert,

The Lancet Oncology

2012

247

Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations

Carsten Schwäenen, Swen Weßendorf, Tatjana Salvi,

Proceedings of the National Academy of Sciences

2004

237

Page 1